8-KThe WireRoutine
Shareholder Vote
Filed Jun 30, 2026 · 11h ago · Accession 0001213900-26-073847
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K
- Filing date
- Jun 30, 2026
- Report date
- Jun 29, 2026
- Document
- ea029661701-8k_estrella.htm
- Size
- 238 KB